Ivy Rx vs LifeMD

Neither Ivy Rx nor LifeMD has an FDA warning letter on record. No price lines up like for like: Ivy Rx and LifeMD publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Ivy Rx / LifeMD

Ivy Rx logo

Ivy Rx

7.3/10

LifeMD logo

LifeMD

6.0/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Brand-name only; no compounding
Lowest standing price
$197/moCompounded semaglutide injection
$298/moBrand-name semaglutide pill
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Ivy Rx nor LifeMD pays us. Links to them earn nothing. Scores: Ivy Rx 7.3, LifeMD 6.0. How we are paid

What the record shows

  1. 01

    Neither Ivy Rx nor LifeMD has an FDA warning letter on record.

  2. 02

    Ivy Rx names no compounding pharmacy in our record. LifeMD sells brand-name medication only.

  3. 03

    No price lines up like for like: Ivy Rx and LifeMD publish prices for different products.

  4. 04

    Only Ivy Rx lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only LifeMD lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Ivy Rx

LifeMD

Compounded semaglutide injection

$197/mo

$2,364 a year

Not sold or not priced
Compounded tirzepatide injection

$297/mo

$3,564 a year

Not sold or not priced
Brand-name semaglutide pen
Not sold or not priced

$348/mo

$4,176 a year

Brand-name tirzepatide pen
Not sold or not priced

$448/mo

$5,376 a year

Brand-name semaglutide pill
Not sold or not priced

$298/mo

$3,576 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, labs, coaching
Billed separately
Not stated
Medication
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None
Refunds
All transactions are final; no returns
Money-back guarantee after 12 months if under 10% loss and all conditions met
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Ivy Rx: July 10, 2026. LifeMD: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Ivy Rx

7.3/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which LifeMD does not price
  • Names no compounding pharmacy

The case for LifeMD

6.0/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Ivy Rx does not price
  • Price leaves out medication

Scores

Ivy Rx 7.3 · LifeMD 6.0 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.5A
vs
B
5.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

Ivy Rx vs LifeMD: questions

Neither Ivy Rx nor LifeMD has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Ivy Rx names no compounding pharmacy in our record. LifeMD sells brand-name medication only.
No price lines up like for like: Ivy Rx and LifeMD publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Ivy Rx states you can cancel at any time; refunds: all transactions are final; no returns. LifeMD states you can cancel at any time; refunds: money-back guarantee after 12 months if under 10% loss and all conditions met.
Neither Ivy Rx nor LifeMD pays us. Links to them earn nothing. Scores: Ivy Rx 7.3, LifeMD 6.0.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks